How much does a box of Olaparib targeted drug cost?

Olaparib is the first PARP inhibitor and the first targeted therapy to block the DNA damage response (DDR) in homologous recombination repair (HRR)-deficient cells/tumors, such as cells/tumors with BRCA1 and/or BRCA2 mutations, or cells/tumors induced by other drugs (such as new hormonal drugs-NHAs).

Olaparib is currently approved in multiple countries for PARP-dependent tumor types with defects and dependencies in the DDR pathway, including maintenance treatment of platinum-sensitive recurrent ovarian cancer, as monotherapy and in combination with bevacizumab for BRCA-mutated (BRCAm) and homologous repopulation First-line maintenance therapy for group repair defect (HRD)-positive advanced ovarian cancer; for germline BRCAm, HER2-negative metastatic breast cancer (in the EU and Japan, this includes locally advanced breast cancer); for germline BRCAm metastatic pancreatic cancer; and for HRR gene-mutated metastatic castration-resistant prostate cancer (BRCAm only in the EU and Japan).

Lynparza The original drug has been launched in China and has entered the scope of Class B medical insurance, but it is only available to patients who meet the indications. The price of each box of 150mg*56 tablets may be around RMB 6,000. There are price differences for drugs of different specifications. There are also Olaparibgeneric drugs produced overseas. The specifications produced by Bangladesh pharmaceutical factories150mg*120 tablets per box may cost around RMB 4,000 (the price may fluctuate due to the exchange rate). Its drug ingredients are basically the same as those of the Olaparib original drug. For more drug information and specific prices, please consult Yaode Medical Consultant.